Compensation award — excluded from discretionary-purchase analysis.
Loading…
Traded Nov 17, 2025 · Filed Nov 19, 2025
Ciena's SVP Global R&D sold $237K of Ciena shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$236,783
Shares × reported transaction price
74 days after results of Sep 4, 2025, 24 days before results of Dec 11, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $191.78 on Nov 17, 2025, 258% above its 52-week low and 8% below its high, after a 25% rise over the previous 30 trading days
52-week range $53.50 (Apr 4, 2025) to $209.52 (Nov 12, 2025), 89% of the way up, from 250 adjusted closes. 30 trading days earlier: $153.25 on Oct 6, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +6.1% | +2.6% | +3.5% |
| 30 days | +22.0% | +2.7% | +19.3% |
| 90 days | +60.1% | +3.0% | +57.1% |
| 180 days | +177.8% | +11.5% | +166.4% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.